Skip to main content
Clinical Trials/NCT00678340
NCT00678340CompletedPhase 4

A Single Centre, Randomized, Single Blinded Trial of Wide Area Circumferential Ablation With Pulmonary Vein Isolation Compared to a Multipolar, Circular Ablation Catheter in Patients With Paroxysmal Atrial Fibrillation

Pier Lambiase1 site in 1 country178 target enrollmentStarted: September 1, 2007Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
178
Locations
1
Primary Endpoint
Freedom of AF at 1 year following AF ablation procedure measured by 7 day holter recording

Study Overview

Brief Summary

Atrial fibrillation (AF) is a chaotic heart rhythm of the top chambers of the heart. AF occurs in up to 10% of the population over the age of 60. It is associated with tiredness, impaired functional capacity and is the cause of up to 10% of strokes.

Ablation is a procedure performed with small tubes (catheters) that are introduced through the top of the leg. Burns are made inside of the heart to treat AF. This procedure has been shown to cure 90% of patients with intermittent (paroxysmal) AF.

The investigators currently use either one of two different catheters to create these burns inside the heart. The investigators do not know which is the best catheter to use in patients with paroxysmal atrial fibrillation.

The investigators study will randomly allocate patients to have their ablation performed by either one of the catheters to give a fair comparison between the two. The investigators objective is to study the differences between these two catheters.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with paroxysmal AF with a planned ablation procedure

Exclusion Criteria

  • Prior AF ablation
  • LA size greater than 60mm
  • Mechanical prosthetic MVR
  • Hypertrophic cardiomyopathy

Outcomes

Primary Outcomes

Freedom of AF at 1 year following AF ablation procedure measured by 7 day holter recording

Time Frame: 1 year

Procedural time for pulmonary vein isolation

Time Frame: Index procedure

Secondary Outcomes

  • All procedural complications(Index)
  • Incidence of pulmonary vein stenosis measure by MRI at 6 months post procedure(6 months)
  • Quality of life questionnaire(6 months and 1 year)

Investigators

Sponsor
Pier Lambiase
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Pier Lambiase

Chief Investigator

University College London Hospitals

Study Sites (1)

Loading locations...

Similar Trials